Editor's Choice for August 2016
22 Aug 2016
Editor's Choice for August 2016
Metformin in cancer prevention
Surgical advances in colorectal cancer care
Updates in prostate and bladder cancer therapy
Lung cancer immunotherapy
'Other' targets in lung cancer
Developments in gastrointestinal tumour treatment
Towards deciphering the functional genetics and neo-antigenic landscape in melanoma
Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?
Polycomb repressors and epigenetic therapy
DNA repair and mutations as targets for personalised therapy
The changing process of drug discovery and design